Last reviewed · How we verify

NCT05550480

Effect of Continuous Glucose Monitoring on Hypoglycemia in Adults With Pancreatogenic Diabetes

Completed NA Last updated 4 October 2024
What this trial tests

NA trial testing Continuous glucose monitoring in Pancreatogenic Type 3C Diabetes Mellitus in 30 participants. Completed in 5 June 2024.

Timeline
8 September 2022
Primary endpoint
5 June 2024
5 June 2024

Quick facts

Lead sponsorAalborg University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment30
Start date8 September 2022
Primary completion5 June 2024
Estimated completion5 June 2024
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University Hospital

Who can join

Adults 18 to 85, any sex, with Pancreatogenic Type 3C Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the effect of continuous glucose monitoring (CGM) (compared to self-monitoring) on hypoglycemia and glycemic control in patients with insulin-treated pancreatogenic diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trial.
    Davidsen L, Cichosz SL, Stæhr PB, Vestergaard P, et al · · 2025 · cited 1× · PMID 40099620 · DOI 10.1111/dom.16356

Verify or expand the search:

Other trials of Continuous glucose monitoring

Trials testing the same drug.

Other Aalborg University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05550480.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing